Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

NICE recommends Gazyvaro not widely used to treat leukaemia

NICE says it is unable to recommend obinutuzumab to treat leukaemia

A new leukaemia drug, which has been hailed for offering hope to many patients who previously had nowhere left to turn, should not be used widely in the NHS, health officials have provisionally said.

Subscribe for full online access and get...

  • An archive of around 6,000 peer-reviewed clinical articles
  • A personal e-Portfolio to store and save CPD and revalidation evidence
  • Online learning units on fundamental aspects of nursing care
  • Nursing news and analysis and customised email alerts
  • Bite-size learning through NT Self-assessment NT Journal club

Register for guest access to keep reading and get...

  • A free taste of selected articles each month
  • Daily email newsletters
  • Access to two free online learning units

Speak with a member of the team about providing Nursing Times for your whole team
Are you a student nurse? Take advantage of a discounted rate by clicking here (Graduation date required)
Already have an account? Sign in